Elicitation of predictable immune responses by using live bacterial vectors (Q34164581)

31 July 2017

1 reference

title

Elicitation of predictable immune responses by using live bacterial vectors (English)

1 reference

31 July 2017

Drabner B

1

1 reference

31 July 2017

Guzmán CA

series ordinal

2

1 reference

31 July 2017

publication date

1 March 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

75-82

1 reference

Modulation of immune responses following antigen administration by mucosal route

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Mucosal immunity to infection with implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

The importance of Th2 cytokines in protective immunity to nematodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Th2 cells: help for helminths

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

A recombinant BCG vaccine generates a Th1-like response and inhibits IgE synthesis in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Regulation of host immune responses by modification of Salmonella virulence genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Oral somatic transgene vaccination using attenuated S. typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

An autologous oral DNA vaccine protects against murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Transgene as vaccine for chlamydia

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Interaction of Salmonella enterica serotype Typhimurium with dendritic cells is defined by targeting to compartments lacking lysosomal membrane glycoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

The defined attenuated Listeria monocytogenes delta mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Delivery of epitopes by the Salmonella type III secretion system for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Protective immune responses against protease-like antigens of the murine malaria parasite Plasmodium vinckei

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

BERNA: a century of immunobiological innovation

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Clinic and diagnosis of enteric infections in man by Yersinia enterocolitica (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Interaction of Yersinia with host cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Yersinia enterocolitica O:9 as a potential live oral carrier for protective antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Oral immunization against cholera toxin with a live Yersinia enterocolitica carrier in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Yersinia pathogenicity factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Molecular and cellular mechanisms of tissue invasion by Shigella flexneri

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Immunity in Shigellosis. I. Response of Man to Attenuated Strains of Shigella

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Construction and characterization of a live attenuated vaccine candidate against Shigella dysenteriae type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Induction of a humoral immune response to a Shiga toxin B subunit epitope expressed as a chimeric LamB protein in a Shigella flexneri live vaccine strain.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Protein-protein interactions in the assembly of Shigella flexneri invasion plasmid antigens IpaB and IpaC into protein complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

The genetic reconstruction of BCG as a new immunotherapeutic tool.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Recombinant BCG as a candidate oral vaccine vector.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Bacterial vaccine vectors and bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Oral vaccination of white-tailed deer using a recombinant Bacillus Calmette-Guérin vaccine expressing the Borrelia burgdorferi outer surface protein A: prospects for immunocontraception

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: MalE

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1389-0344%2800%2900072-1

7 January 2021

10.1016/S1389-0344(00)00072-1

Identifiers

DOI

1 reference

31 July 2017

1 reference